To evaluate the impact of chronic inflammation on marginal zone B cells representation, we stained splenocytes from crt−/− FLC and mice with IBD with B220 together with CD21 and CD23 specific antibodies. This evidence concerns the gene CR2 and inflammatory bowel disease.